CYSTINOSIS

Course overview

CYSTINOSIS IS A RARE AUTOSOMAL RECESSIVE LYSOSOMAL STORAGE DISORDER CAUSED BY A MALFUNCTIONING OF THE PROTEIN CYSTINOSIN, WHICH IS ENCODED BY THE CTNS GENE. THIS DISORDER IS CHARACTERIZED BY THE ACCUMULATION OF CYSTINE WITHIN CELLULAR LYSOSOMES, LEADING TO WIDESPREAD ORGAN INVOLVEMENT. IN NEPHROPATHIC OR INFANTILE CYSTINOSIS, RENAL ISSUES ARE THE PRIMARY CAUSE OF MORBIDITY AND MORTALITY, AND IT IS ALSO THE MOST COMMON INHERITED CAUSE OF FANCONI SYNDROME IN CHILDREN. CYSTINOSIS HAS 3 FORMS—INFANTILE (NEPHROPATHIC), JUVENILE (INTERMEDIATE AND LATE-ONSET), AND ADULT (BENIGN, OCULAR, AND NON-NEPHROPATHIC). THE INFANTILE FORM IS THE MOST COMMON AND SEVERE, ACCOUNTING FOR ABOUT 95% OF CASES, AND LEADS TO END-STAGE RENAL DISEASE (ESRD) BY AGES 10 TO 12. THE EYES AND ENDOCRINE ORGANS ARE ALSO SIGNIFICANTLY AFFECTED, CONTRIBUTING TO THE CONDITION'S OVERALL MORBIDITY.CYSTEAMINE, A CYSTINE-DEPLETING MEDICATION, IS THE CORNERSTONE OF TREATMENT FOR CYSTINOSIS, SIGNIFICANTLY DELAYING DISEASE PROGRESSION AND IMPROVING OUTCOMES. EARLY DIAGNOSIS AND PROMPT TREATMENT WITH CYSTEAMINE ARE CRUCIAL FOR MANAGING THE DISEASE AND PREVENTING COMPLICATIONS, INCLUDING THE PROGRESSION TO ESRD. THIS ACTIVITY COVERS THE EPIDEMIOLOGY, PATHOPHYSIOLOGY, MOLECULAR GENETICS, CLINICAL PRESENTATION, AND EVALUATION OF CYSTINOSIS, ALONG WITH THE IDENTIFICATION AND MANAGEMENT OF COMMON COMPLICATIONS. THIS ACTIVITY ALSO HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN THE LONG-TERM MANAGEMENT OF CYSTINOSIS AND IN IMPROVING PATIENT OUTCOMES.